Company / Current Liabilities per Share
Eloxx Pharmaceuticals, Inc. Current Liabilities per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$7.22
FY2025
5-year range
$0.02 / $7.22
FY2021-FY2025
Trend
+36596.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +36596% YoY in FY2025, a notable deviation from the 3-year average annual change of +12146%.
Based on SEC 10-K filings.
7.22 in FY2025 with a 10-year CAGR of +62.5%.
Increased from $0.06 to $7.22 over the past 10 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +62.5%
Key checks
Key Insights
- In FY2025, current liabilities per share increased 36596.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.22 | +36596.2% |
| FY2016 | $0.02 | -65.0% |
| FY2015 | $0.06 | -93.0% |
| FY2014 | $0.80 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026